Literature DB >> 18347451

Frequency of anti-retinal antibodies in normal human serum.

Kaori Shimazaki1, Guy V Jirawuthiworavong, John R Heckenlively, Lynn K Gordon.   

Abstract

BACKGROUND: Anti-retinal antibodies have been described in the context of autoimmune retinopathies and are often presumed to be pathogenic or disease associated. However, full characterization of patterns of anti-retinal antibody reactivity in normal human serum has been limited. The purpose of this work was to identify the profile of anti-retinal IgG antibodies in serum used as controls in laboratory testing.
METHODS: Normal human sera used in commercial diagnostic laboratories were tested for the presence of immunoreactivity against soluble human retinal proteins using Western blot analysis of fractionated soluble human retinal proteins. Reactivity was quantified using computerized densitometry, and the level of reactivity was standardized relative to a control positive serum with known reactivity against recoverin.
RESULTS: Some anti-retinal reactivity was observed in the majority of all tested normal sera. Reactivity against one to two protein bands was observed in 33%. Reactivity against five or more distinct bands was observed in 22%. There was a tendency for serum from women to react with three or more protein bands compared with serum from men.
CONCLUSIONS: The presence of anti-retinal antibodies is observed in a majority of normal control human sera, suggesting that identification of new candidate retinal autoantigens should be cautiously interpreted and subject to rigorous testing for disease association. Additional studies will aid development of a standardized protocol for validation of potential pathogenic seroreactivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347451     DOI: 10.1097/WNO.0b013e318167549f

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  24 in total

1.  Slowly progressive non-neoplastic autoimmune-like retinopathy.

Authors:  Kouichi Ohta; Takanobu Kikuchi; Noriko Yoshida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-13       Impact factor: 3.117

Review 2.  The need for standardization of antiretinal antibody detection and measurement.

Authors:  Farzin Forooghian; Ian M Macdonald; John R Heckenlively; Elise Héon; Lynn K Gordon; John J Hooks; Barbara Detrick; Robert B Nussenblatt
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

Review 3.  The enigma of autoimmune retinopathy.

Authors:  Farzin Forooghian; Sijia Cao; Jing Cui; Joanne A Matsubara
Journal:  Int Ophthalmol Clin       Date:  2015

4.  Unilateral negative electroretinogram presenting as photophobia.

Authors:  Ai Kido; Ken Ogino; Yozo Miyake; Kazuo Yanagida; Takanobu Kikuchi; Nagahisa Yoshimura
Journal:  Doc Ophthalmol       Date:  2016-05-31       Impact factor: 2.379

5.  Hyperautofluorescent ring in autoimmune retinopathy.

Authors:  Luiz H Lima; Jonathan P Greenberg; Vivienne C Greenstein; R Theodore Smith; Juliana M F Sallum; Charles Thirkill; Lawrence A Yannuzzi; Stephen H Tsang
Journal:  Retina       Date:  2012-07       Impact factor: 4.256

6.  Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.

Authors:  Grazyna Adamus
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-03-09       Impact factor: 4.799

Review 7.  Non-paraneoplastic related retinopathy: clinical challenges and review.

Authors:  Júlia T Takiuti; Vitor K L Takahashi; Christine L Xu; Ruben Jauregui; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2019-08-08       Impact factor: 1.803

8.  Papilloedema and Autoimmune Retinopathy from Systemic Lupus Erythematosus.

Authors:  John J Chen; Neeraj Kumar; Kathleen M McEvoy; Jacqueline A Leavitt
Journal:  Neuroophthalmology       Date:  2017-08-18

9.  Potential for autoimmune pathogenesis of Rift Valley Fever virus retinitis.

Authors:  Shoshana Newman-Gerhardt; Samuel Muiruri; Eric Muchiri; Clarence J Peters; John Morrill; Alexander H Lucas; Charles H King; James Kazura; Angelle Desiree LaBeaud
Journal:  Am J Trop Med Hyg       Date:  2013-08-05       Impact factor: 2.345

10.  Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.

Authors:  Anke Ziegenbalg; Rafael Prados-Rosales; Elisabeth R Jenny-Avital; Ryung S Kim; Arturo Casadevall; Jacqueline M Achkar
Journal:  Tuberculosis (Edinb)       Date:  2013-04-02       Impact factor: 3.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.